Schroder Investment Management Group
IGMS

Schroder Investment Management Group’s IGM Biosciences IGMS Stock Holding History

Schroder Investment Management Group’s Portfolio IGMS Stock Details IGMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-26,833
Closed -$456K – 1286
2022
Q4 		$456K Buy
+26,833
New +$537K ﹤0.01% 1167

Other funds holding IGMS

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Schroder Investment Management Group's IGMS Position: Q1 2023 in Review

Schroder Investment Management Group sold out of IGM Biosciences (IGMS) in Q1 2023, closing a stake of 26,833 shares — an estimated $456K sold.

Schroder Investment Management Group first reported a position in IGMS in Q4 2022 and held it in 1 quarter. The position peaked at $456K in Q4 2022. 74 funds tracked by Wall St. Rank hold IGMS as of Q1 2023.

  • Schroder Investment Management Group reported no remaining IGM Biosciences position as of Q1 2023 after selling out during the quarter.
  • Schroder Investment Management Group sold 26,833 IGM Biosciences shares in Q1 2023, an estimated $456K.
  • Schroder Investment Management Group first reported a position in IGM Biosciences in Q4 2022 and held it in 1 quarter.
  • Schroder Investment Management Group's IGM Biosciences position peaked at $456K in Q4 2022.
  • 74 funds tracked by Wall St. Rank held IGM Biosciences as of Q1 2023.

Based on Schroder Investment Management Group's 13F filing for Q1 2023, filed 11 May 2023.